,62 Thus, we believe that pruning of dysfunctional non-HEV tumor blood vessels upon anti-CTLA-4 treatment, resulting from the anti-angiogenic effects of IFNγ, will lead to an increased functionality and a better perfusion of the remaining vessels, including TA-HEVs. The gene discussed is IFNG; the disease is neoplasm.